(SOURCE: MCGILL UNIVERSITY) – Ocrelizumab shown to reduce new attacks/symptom progression in some patients. In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients […]
(SOURCE: UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON) – Positive results of an investigational medication study for primary progressive multiple sclerosis were published online in today’s New England Journal of Medicine […]
(SOURCE: TECHNICAL UNIVERSITY OF MUNICH) – T cells are an important part of the immune system. However, they are not only capable of destroying pathogens. They can also become harmful […]
(Medical News Today) According to a recent article published in Medical News Today, most people with Multiple Sclerosis are initially diagnosed with relapsing-remitting MS (RRMS). In RRMS, there are clear […]
(Multiple Sclerosis News Today) According to a recent article published in Multiple Sclerosis Today, therapies which are aimed at regenerating the myelin sheath can work to restore proper brain activity […]
(MedScape) According to a recent article published in MedScape, a possible blood test for Multiple Sclerosis (MS) is currently being studied.
(News-medical.net) According to a recent article published in news-medical.net, a new Tel Aviv University study which was published in the Journal of the American Chemical Society (JACS) located a structural instability in […]
(Medical Daily) According to a recent study published in Neurology, treating multiple sclerosis (MS) early may help reduce likelihood of being diagnosed with clinical MS.